Call for Abstract

7th International Conference on Drug Discovery and Toxicology, will be organized around the theme “New Era Technologies in Drug Formulation & Novelties in Toxicology”

Drug Discovery Congress 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Drug Discovery Congress 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Diagnostic markers as therapeutic targets
  • Track 1-2Approaches in target identification and validation
  • Track 1-3In silico pharmacology
  • Track 1-4Drug design and molecular modeling
  • Track 1-5Transdermal drug delivery
  • Track 1-6Site-specific drug delivery
  • Track 2-1Drug synthesis and pharmaceutical formulation
  • Track 2-2Pharmacological interactions
  • Track 2-3Mechanism of drug action
  • Track 2-4Drug screening and toxicity assessments
  • Track 3-1Preclinical research
  • Track 3-2Phases of clinical trial
  • Track 3-3Drug approval process
  • Track 3-4Pharmacokinetic and pharmacodynamics dosage studies
  • Track 4-1Advanced pharmaceutical carriers
  • Track 4-2Prodrugs
  • Track 4-3Transdermal drug delivery
  • Track 4-4Site-specific drug delivery
  • Track 5-1Predictive prescribing
  • Track 5-2Toxgnostics
  • Track 5-3Clinomics
  • Track 5-4Molecular medicines
  • Track 6-1Use of radioisotopes in medicine
  • Track 6-2Radiopharmaceuticals- design and manufacture
  • Track 6-3Radionuclide therapy
  • Track 6-4Radioimmunotherapy
  • Track 7-1Neuroactive drugs
  • Track 7-2Molecular Neuropharmacology
  • Track 7-3Clinical trials in psychopharmacology
  • Track 7-4Drug addiction
  • Track 8-1Bioprospecting
  • Track 8-2Bioactive molecules
  • Track 8-3Home remedies
  • Track 8-4Nutraceuticals
  • Track 9-1Probiotic microbiota and synbiotics
  • Track 9-2Enteric microflora and its therapeutic manipulation
  • Track 9-3Prebiotic sources and its production strategy
  • Track 10-1Therapeutic properties of nanomaterials
  • Track 10-2Nanoparticles as drug vehicles
  • Track 10-3Role of nanotechnology in drug design and manufacture
  • Track 10-4Biocompatibility of nanoparticles
  • Track 11-1Small molecule inhibitors as cancer therapeutics
  • Track 11-2Tumor angiogenesis inhibition
  • Track 11-3Chemotherapy-induced autophagy
  • Track 11-4Oncogenomics in drug design